The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index; 26 of the 115 sources its claims cite were checked for support.
The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing
Open accessAbstract
Biopharmaceuticals have revolutionized the field of medicine in the types of active ingredient molecules and treatable indications. Adoption of Quality by Design and Process Analytical Technology (PAT) frameworks has helped the biopharmaceutical field to realize consistent product quality, process intensification, and real-time control. As part of the PAT strategy, Raman spectroscopy offers many benefits and is used successfully in bioprocessing from single-cell analysis to cGMP process control. Since first introduced in 2011 for industrial bioprocessing applications, Raman has become a first-choice PAT for monitoring and controlling upstream bioprocesses because it facilitates advanced process control and enables consistent process quality. This paper will discuss new frontiers in extending these successes in upstream from scale-down to commercial manufacturing. New reports concerning the use of Raman spectroscopy in the basic science of single cells and downstream process monitoring illustrate industrial recognition of Raman’s value throughout a biopharmaceutical product’s lifecycle. Finally, we draw upon a nearly 90-year history in biological Raman spectroscopy to provide the basis for laboratory and in-line measurements of protein quality, including higher-order structure and composition modifications, to support formulation development. Graphical abstract
Overview
CoChat Summary
TL;DR
This review argues that Raman spectroscopy has become a first-choice process analytical technology for biopharmaceutical upstream bioprocessing and is expanding into downstream monitoring, formulation, and higher-order structure analysis. It synthesizes regulatory, instrumentation, chemometric, and application literature spanning single-cell studies to cGMP manufacturing.
Key findings
- Raman is described as a first-choice PAT for upstream bioprocessing since its first industrial upstream description in 2011, with advantages in specificity, aqueous compatibility, and in-line sampling; applications now include glucose, lactate, amino acids, pH, cell attributes, and product concentration.
- Generic Raman models can transfer across cell lines and scales: in Webster et al. 2018, glucose models gave R²p of 0.99, 0.98, and 0.99 with RMSEP of 0.47, 0.43, and 0.41 g/L across two new cell lines and a 10 L scale, while glutamate and product concentration were exceptions. Local just-in-time learning models improved RMSE from 4.4% (sodium) to 44.89% (ammonium) for PLS and from 9.2% (sodium) to 53.46% (ammonium) for Gaussian process models.
- Downstream applications are emerging: Yilmaz et al. reported an IgG model RMSEP of 0.18 g/L across IgG subclasses; Feidl et al. reported an optimized model average RMSEP of 0.12 mg/mL within 0–2.82 mg/mL and an average limit of detection of 0.24 mg/mL; Rafferty et al. found Raman-based feed volumes were within 6% or less of capacitance-based feed volumes after day 3.
- Raman has a nearly 90-year history in biological spectroscopy, supporting protein higher-order structure and formulation work; examples include deep-UV resonance Raman for mAb structure, possible glycation markers at ~1040 cm⁻¹ and 1121 cm⁻¹, and lysozyme fibril formation studies.
Methods
- Design: narrative/critical review, not a primary experimental study; it updates the authors’ 2016 review and synthesizes literature on Raman in biopharmaceutical development and manufacturing.
- Data or sample: cited studies cover CHO cells, T-cells, E. coli, mAbs, IgG, lysozyme, and other proteins, with scales from high-throughput miniature bioreactors (15 μL–250 mL) to pilot/commercial manufacturing (>20 L to thousands of L); one cited study spanned 35 cultivations, 4 CHO cell lines, 8 clones, 4 scales, and 2 cultivation modes.
- Main analysis: thematic synthesis of regulatory frameworks, Raman variants and instrumentation, chemometric model development, and applications in upstream monitoring/control, downstream monitoring, and product formulation/higher-order structure; tables summarize model figures of merit and preprocessing approaches.
Limitations
- The paper states that Raman has inherent drawbacks, including the “excessive feebleness” of the effect and competition with fluorescence; fluorescence-reduction and enhancement variants such as time-gated Raman and SERDS are described as early-stage, often limited to off-line or laboratory use, and not clearly advantageous over spontaneous Raman at higher wavelengths or software-based correction.
- The paper states that downstream publications have been limited until recently, partly because downstream operations are fast and cycle time limits spectral acquisition with standard immersion probes, and because finding a cost-effective benefit over existing measurements such as UV–Vis can be difficult; SERS is also noted as having an acknowledged limitation in translating enhancement into reliable, quantifiable measurement.
- Evident from the text: as a review, it does not present new experimental data or a systematic meta-analysis, and its cited model performance values come from heterogeneous studies with different cell lines, scales, preprocessing, and reference methods.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Example of experimental approach for Raman model development. Optimization of model performance is an iterative process involving data preprocessing, algorithm selection, calibration, and validation. While there are steps toward automating model development, it remains a manually intensive process. Raman data were first input into various methods for variable selection including principal components analysis (PCA), multiple linear regression (MLR), principal components regression (PCR), partial least-squares or projection to latent structures (PLS), or variable importance in projection (VIP). Data were then pre-processed using Savitzky-Golay first or second derivative, SNV, multiplicative scatter correction, and mean center or autoscale. MLR, PCR, and PLS regression were used to model data. Figure permissions: figure reused from Kozma et al. paper with permission from publisher, [51] © 2018 Elsevier B.V. All rights reserved](/paper-figures/8a0408ea8087469eb6fa98481570804f/the-role-of-raman-spectroscopy-in-biopharmaceuticals-from-development-to-figure-2.jpg)

Verification
Claims the paper makes
21 Valid · 17 Not valid · 70 Not checked · 81 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Variations in the geometry of optical fibers and lenses within the probe can enable a variety of sampling options including backscattered, large volumetric, spatially offset Raman, and transmission Raman.”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Overview of instrumentation and data analysis > Sampling at the macro- and bulk scale
What the sources say
- Supportedcites [18] Esmonde-White KA, Cuellar M, Uerpmann C, Lenain B, Lewis IR. Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing. Anal Bioanal Chem. 2017;409(3):637–49. source
The Instrumentation and data analysis techniques section (page not supplied) describes how excitation and collection geometry produces backscattered, large-volumetric, spatially offset, and transmission Raman sampling. It identifies fiber placement, beam width, and collection through the sample as the relevant differences. (LLM, conf=0.93)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The model for methionine did not perform as well as the other three models”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Applications in biopharmaceutical manufacturing > Upstream monitoring and control
What the sources say
- Supportedcites [74] Bhatia H, Mehdizadeh H, Drapeau D, Yoon S. In-line monitoring of amino acids in mammalian cell cultures using Raman spectroscopy and multivariate chemometrics models. Eng Life Sci. 2018;18(1):55–61. source
The Results and discussion section states that all three other amino-acid models predicted well, whereas the methionine model did not. It reports a lower R² and Q² and a higher RMSEP for methionine; the Concluding remarks likewise say its performance was lower than that of the other three models. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Overall, the Bhatia et al. [74] and Webster et al. [73] studies establish the feasibility of Raman spectroscopy to quantify amino acids in-line during a cell culture bioprocess.”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Applications in biopharmaceutical manufacturing > Upstream monitoring and control
What the sources say
- Supportedcites [74] Bhatia H, Mehdizadeh H, Drapeau D, Yoon S. In-line monitoring of amino acids in mammalian cell cultures using Raman spectroscopy and multivariate chemometrics models. Eng Life Sci. 2018;18(1):55–61. source
The Concluding remarks describe the study as a proof of concept for Raman-based, real-time monitoring of amino acid concentrations in cell culture media. The Analytical methods describe in-line Raman spectra collected through a probe integrated with bioreactors. The paper reports acceptable predictive accuracy for three amino acids, while noting that its methionine model performed less well. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [73] Webster TA, Hadley BC, Dickson M, Busa JK, Jaques C, Mason C. Feedback control of two supplemental feeds during fed-batch culture on a platform process using inline Raman models for glucose and phenylalanine concentration. Bioprocess Biosyst Eng. 2021;44(1):127–40. source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Raman and UV-resonance Raman spectroscopy are now established biophysical tools that complement other analyses in the PAT toolbox to understand protein higher-order structure [113].”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Applications in biopharmaceutical manufacturing > Higher-order structure
What the sources say
- Partly supportedcites [113] Pauk JN, Raju Palanisamy J, Kager J, Koczka K, Berghammer G, Herwig C, et al. Advances in monitoring and control of refolding kinetics combining PAT and modeling. Appl Microbiol Biotechnol. 2021;105(6):2243–60. sourceExperimental — accuracy not yet measured
The Raman spectroscopy section says Raman can assess protein secondary structure, disulfide bonds and conformational changes, supporting its use alongside other structural analyses. It does not identify UV-resonance Raman as an established PAT tool; it discusses different resonance Raman variants and says those variants are unsuitable for real-time monitoring of protein refolding. No page numbers are available in our copy. (LLM, conf=0.86)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Baradez et al. [78] showed success in Raman-based monitoring of glucose, lactate, glutamate, glutamine, and ammonium during the cultivation of T-cells derived from human donors.”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Applications in biopharmaceutical manufacturing > Upstream monitoring and control
What the sources say
- Partly supportedcites [78] Baradez M-O, Biziato D, Hassan E, Marshall D. Application of Raman spectroscopy and univariate modelling as a process analytical technology for cell therapy bioprocessing. Front Med. 2018;5:47. sourceExperimental — accuracy not yet measured
The Results (Chemometric Modeling; page not available) report Raman models for all five analytes during T-cell culture using material from four donors. The claim overstates their success for glutamate: the model captured only a general trend and lost correlation above 0.16 g/L. Ammonia monitoring also became less reliable at higher concentrations. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
63 more claims · 4 with their cited sources checked
Create a free account to see all 189 claims and every source verdict.
- It may state two separate claims as one. 67
- Probably not a substantial claim. 85
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Enhanced variants of Raman include resonance Raman, surface‐enhanced Raman (SERS), surface‐enhanced resonance Raman (SERRS) and tip‐enhanced Raman (TERS), all of which are used for their inherent advantages including increased Raman signal, reduced limit of detection and the usage of reduced sample volume [74].”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Applications in biopharmaceutical manufacturing > Upstream monitoring and control
“The model RMSEP, 0.42 mL/L for glucose, and 21.3 mg/L for phenylalanine”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Applications in biopharmaceutical manufacturing > Upstream monitoring and control
“GlucoseRange: ~ 0–11 g/LRMSEP: 0.42 g/L”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Overview of instrumentation and data analysis > Raman data analysis
“After FMEA, eight major risks were initially identified:”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Overview of instrumentation and data analysis > Raman data analysis
“scale, base powder, reference method errors, cultivation mode, final media composition, main feed, clone, cell line, media lot, and temperature.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > Applications in biopharmaceutical manufacturing > Upstream monitoring and control
“A follow-on study by Rafferty et al. [52] had explored the use of Raman spectroscopy to support feeding strategies based on cell health, as measured by capacitance.”
§ The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing > References
“77. Rafferty C O’Mahony J Rea R Burgoyne B Balss KM Lyngberg O Raman spectroscopic based chemometric models to support a dynamic capacitance based cell culture feeding strategy Bioprocess Biosyst Eng 2020 43 8 1415 1429 32303846”
Citations
Cites
Present and Future of Surface-Enhanced Raman Scattering
Langer, J., Jimenez de Aberasturi, D., Aizpurua, J., Alvarez-Puebla, R. A., Auguié, B., Baumberg, J. J., Bazan, G. C., Bell, S. E. J., Boisen, A., Brolo, A. G., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b04224 · Cited by 3,880 · cited 7×
“Both SERS and TERS are valuable for nanoscale analysis with applications in cell-ligand binding, single-cell dynamics, hyper-localized molecular structure, or intracellular studies.”
BackgroundInfluentialA New Type of Secondary Radiation
RAMAN, C. V., & KRISHNAN, K. S. (1928) · Nature · doi:10.1038/121501c0 · Cited by 2,647 · cited 2×
“When scattering occurs, there are three possible outcomes: the first outcome results in the creation of scattered photons having the same energy as the incoming photon; the second outcome results in the scattered photons losing some energy (resulting in a red-shifted wavelength); and the third outcome results in the s…”
BackgroundProduction of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 1×
“Advances in cell engineering, process control, and media composition are credited with improving the volumetric yield of cell culture bioprocesses, making biopharmaceutical manufacturing more cost-effective and practical [8].”
BackgroundUsing Raman spectroscopy to characterize biological materials
Butler, H. J., Ashton, L., Bird, B., Cinque, G., Curtis, K., Dorney, J., Esmonde-White, K., Fullwood, N. J., Gardner, B., Martin-Hirsch, P. L., et al. (2016) · Nature Protocols · doi:10.1038/nprot.2016.036 · Cited by 1,309 · cited 2×
“These well-known features have been harnessed in biology and biomedical fields to study tissues, cells, and biofluids [64].”
BackgroundSelf-citationBiological Applications of Raman Spectroscopy
(2000) · Infrared and Raman Spectroscopy of Biological Materials · doi:10.1201/b16936-17 · Cited by 1,088 · cited 1×
“It is curious that Raman is mentioned as an emerging technology in recent reviews of higher-order structure analysis tools because Raman has been used for nearly 90 years in biophysical measurements! Raman spectroscopy is an established analytical technique for examining biological macromolecules, protein structure, a…”
BackgroundBiopharmaceutical benchmarks 2018
Walsh, G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4305 · Cited by 978 · cited 2×
“Today, there are over 300 approved biopharmaceutical products on the market, consisting mostly of monoclonal antibodies (mAb) produced by mammalian cells [6].”
BackgroundCoherent Anti-Stokes Raman Scattering Microscopy: Instrumentation, Theory, and Applications
Cheng, J.-X., & Xie, X. S. (2004) · The Journal of Physical Chemistry B · doi:10.1021/jp035693v · Cited by 963
Bell, S. E. J., Charron, G., Cortés, E., Kneipp, J., de la Chapelle, M. L., Langer, J., Procházka, M., Tran, V., & Schlücker, S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201908154 · Cited by 617 · cited 1×
“[34] provided key parameters and recommendations, such as the use of an internal standard, to improve intralaboratory comparison of SERS results.”
BackgroundCrocombe, R. A. (2018) · Applied Spectroscopy · doi:10.1177/0003702818809719 · Cited by 532 · cited 3×
“A detailed discussion on handheld Raman spectroscopy is outside the scope of this paper, and interested readers can learn more on this topic with this excellent review by Crocombe [21].”
BackgroundMethodInfluentialHandbook of Raman Spectroscopy
Lewis, I. R., & Edwards, H. (2001) · CRC Press eBooks · doi:10.1201/9781420029253 · Cited by 528
Self-citation
Research works printed but not linked: 5
- Eesley GL. Coherent Raman spectroscopy. Elsevier; 2013.
- Kaschif Ahmed S, Guenard R, Romero-Torres S, Antoniou C. Hybrid model identification for monoclonal antibody production bioreactor – a digital twin [Internet]. American Pharmaceutical Review. 2019 [cited 2021 Mar 25]. Available from: http://www.americanpharmaceuticalreview.com/Featured-Articles/517739-Hybrid-Model-Identification-for-Monoclonal-Antibody-Production-Bioreactor-A-Digital-Twin/
- Romero-Torres S, Wolfram K, Armando J, Kaschif Ahmed S, Ren J, Hill D, et al. Biopharmaceutical process model evolution- enabling process knowledge continuum from an advanced process control perspective [Internet]. American Pharmaceutical Review. 2018 [cited 2021 Mar 25]. Available from: http://www.americanpharmaceuticalreview.com/Featured-Articles/352447-Biopharmaceutical-Process-Model-Evolution-Enabling-Process-Knowledge-Continuum-from-an-Advanced-Process-Control-Perspective/
- Esmonde-White KA, Cuellar M, Uerpmann C, Lenain B, Lewis IR. Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing. Anal Bioanal Chem. 2016;4(409):637–49.
- Mungikar A, Kamat M. Use of in-line raman spectroscopy as a non-destructive and rapid analytical technique to monitor aggregation of a therapeutic protein. American Pharmaceutical Review [Internet]. 2010 Nov 1 [cited 2016 May 18];13(7). Available from: http://www.americanpharmaceuticalreview.com/Featured-Articles/37071-Use-of-In-line-Raman-Spectroscopy-as-a-Non-destructive-and-Rapid-Analytical-Technique-to-Monitor-Aggregation-of-a-Therapeutic-Protein/
Cited by
Bioprocessing 4.0: a pragmatic review and future perspectives
Isoko, K., Cordiner, J., Kis, Z., & Moghadam, P. Z. (2024) · Digital Discovery · doi:10.1039/d4dd00127c · Cited by 118
Khuat, T. T., Bassett, R., Otte, E. A., Grevis-James, A., & Gabryś, B. (2024) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2024.108585 · Cited by 107
Trends in pharmaceutical analysis and quality control by modern Raman spectroscopic techniques
Silge, A., Weber, K., Cialla‐May, D., Müller-Bötticher, L., Fischer, D., & Popp, J. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116623 · Cited by 86
Challenges and Opportunities of Implementing Data Fusion in Process Analytical Technology—A Review
Casian, T., Nagy, B., Kovács, B., Galata, D. L., Hirsch, E., & Farkas, A. (2022) · Molecules · doi:10.3390/molecules27154846 · Cited by 89
“Raman spectroscopy is gaining importance in biopharmaceutical manufacturing as a multi-attribute multi-dimensional sensor due to its specificity and compatibility with aqueous solutions [63].”
BackgroundBas, T. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147603 · Cited by 88
“…and refinement of new carotenoid formulations in medicine, increasing product stability and solubility, and targeting the delivery of specific carotenoid-based therapeutic drug treatments, thus improving their clinical effect, efficacy, and applicability in the treatment of specific diseases [166].”
BackgroundInfluential
Metadata
- Authors
- Esmonde-White, K. A., Cuellar, M., & Lewis, I. R.
- Venue
- Analytical and Bioanalytical Chemistry
- Published
- 2021-10-20
- Volume
- 414
- Issue
- 2
- Pages
- 969-991
- ISSN
- 1618-2642 (ISSN-L)
- 1618-2650
- PMC
- PMC8724084
- OpenAlex
- W3206542495
- Cited by
- 152
- References
- 112
- Citations by year
- 2026: 43 · 2025: 43 · 2024: 36 · 2023: 20 · 2022: 10
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Analytical and Bioanalytical Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
- Physical Sciences › Chemistry › Analytical Chemistry › Spectroscopy and Chemometric Analyses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- Raman spectroscopy, biopharmaceuticals, process analytical technology, quality by design, upstream bioprocessing, real-time process monitoring, scale-down, bioprocess control, single-cell analysis, protein quality, higher-order structure, protein composition, formulation development
- MeSH terms
- Biological Products, Quality Control, Spectrum Analysis, Raman, Technology, Pharmaceutical, Spectroscopy, Near-Infrared
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing. https://app.cochat.ai/papers/10.1007/s00216-021-03727-4
- The paper
- Esmonde-White, K. A., Cuellar, M., & Lewis, I. R. (2022). The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-021-03727-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.